[mc4wp_form id="313"]

EU Committee Backs Delafloxacin for ABSSSI

Share this post

A European Medicines Agency advisory panel recommended delafloxacin for acute bacterial skin and skin structure infections in adults when other commonly used antibacterial drugs are inappropriate.
International Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply